Activity and Antigen Levels of Thrombin-Activatable Fibrinolysis Inhibitor in Plasma of Patients With Disseminated Intravascular Coagulation

Author： Watanabe R.   Wada H.   Watanabe Y.   Sakakura M.   Nakasaki T.   Mori Y.   Nishikawa M.   Gabazza E.C.   Nobori T.   Shiku H.  

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.104, Iss.1, 2001-10, pp. : 1-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thrombin-Activatable Fibrinolysis Inhibitor in Breast Cancer Patients

By  

Medical Principles and Practice, Vol. 20, Iss. 4, 2011-05 ,pp. : 332-335

Karger

Access to resources Recommend Favorite

Effect of Levothyroxine Suppression Therapy on Plasma Thrombin Activatable Fibrinolysis Inhibitor Antigen Levels in Benign Thyroid Nodules

By  

Medical Principles and Practice, Vol. 20, Iss. 1, 2010-12 ,pp. : 23-28

Karger

Access to resources Recommend Favorite

Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome

By  

Cerebrovascular Diseases, Vol. 42, Iss. 5-6, 2016-07 ,pp. : 404-414

Karger

Access to resources Recommend Favorite

Patients on Peritoneal Dialysis But Not on Hemodialysis Have Elevated Concentration and Activity of Thrombin-Activatable Fibrinolysis Inhibitor

By Hryszko T.   Malyszko J.   Malyszko J.S.   Brzosko S.   Mysliwiec M.  

Thrombosis Research, Vol. 104, Iss. 4, 2001-11 ,pp. : 233-238

Elsevier

Access to resources Recommend Favorite

Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism

By Erem Cihangir  

Endocrine Journal, Vol. 35, Iss. 1, 2009-02 ,pp. : 75-80

Humana Press, Inc

Access to resources Recommend Favorite